05 January 2017

3 ways to Evaluate Vaccination, Build Balanced Trust for Dengue Disease Control

In his contribution to Sanofi Pasteur’s corporate blog, Perspectives, Dr. Cesar Mascareñas, Head of Dengue Global Medical Affairs, outlines how the public health community evaluates new vaccines, from large-scale clinical study – the gold standard – to mathematical modeling and finally, post-authorization, real-world assessment of reductions in disease burdens.  From this point of departure, he shares his views on the conditions for instilling balanced trust in the value of an important and cost-effective public health intervention, such as dengue vaccination.

Read – 3 ways to Evaluate Vaccination, Build Balanced Trust for Dengue Disease Control on Perspectives.